9H2D | pdb_00009h2d

Human IFT172 C-terminal U-box domain crystal structure


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.10 Å
  • R-Value Free: 
    0.238 (Depositor), 0.220 (DCC) 
  • R-Value Work: 
    0.189 (Depositor) 
  • R-Value Observed: 
    0.192 (Depositor) 

Starting Model: in silico
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9H2D

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Intraflagellar transport protein IFT172 contains a C-terminal ubiquitin-binding U-box-like domain involved in ciliary signaling.

Zacharia, N.K.Kuhns, S.Boegholm, N.Christensen, A.Wang, J.Petriman, N.A.Lorentzen, A.Fialova, J.L.Menguy, L.Saunier, S.Christensen, S.T.Andersen, J.S.Bhogaraju, S.Lorentzen, E.

(2026) Elife 14

  • DOI: https://doi.org/10.7554/eLife.104906
  • Primary Citation Related Structures: 
    9H2D

  • PubMed Abstract: 

    Intraflagellar transport (IFT) is a fundamental process driving ciliogenesis in most eukaryotic organisms. IFT172, the largest protein of the IFT complex, plays a crucial role in cilium formation, and several disease-causing IFT172 variants have been identified in ciliopathy patients. While IFT172 is tethered to the IFT-B complex via its N-terminal domains, the function of its C-terminal domains has remained elusive. Here, using both human and Chlamydomonas reinhardtii IFT172, we reveal that the C-terminal part of IFT172 interacts with IFT-A complex subunits, providing a molecular basis for the role of IFT172 in bridging IFT-A and IFT-B complexes. We determine the crystal structure of the C-terminal part of IFT172, uncovering a conserved U-box-like domain often found in E3 ubiquitin ligases. This domain exhibits ubiquitin-binding properties, and IFT172 undergoes ubiquitin conjugation in vitro, an activity that is reduced in the C1727R patient ciliopathy variant. We use CRISPR-engineered RPE-1 cells to demonstrate that the U-box-like domain is essential for IFT172 protein stability and proper cilium formation. Notably, RPE-1 cells with heterozygous deletion of the U-box domain show altered TGF-β signaling responses, particularly in SMAD2 phosphorylation levels and AKT activation. Our findings suggest that IFT172, beyond its structural role in bridging IFT-A and IFT-B complexes within IFT trains, harbors a conserved U-box-like domain with potential involvement in ciliary ubiquitination processes and signaling, providing new insights into the molecular mechanisms underlying IFT172-related ciliopathies.


  • Organizational Affiliation
    • Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.

Macromolecule Content 

  • Total Structure Weight: 61.55 kDa 
  • Atom Count: 4,401 
  • Modeled Residue Count: 529 
  • Deposited Residue Count: 544 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Intraflagellar transport protein 172 homolog
A, B
272Homo sapiensMutation(s): 0 
Gene Names: IFT172KIAA1179
UniProt & NIH Common Fund Data Resources
Find proteins for Q9UG01 (Homo sapiens)
Explore Q9UG01 
Go to UniProtKB:  Q9UG01
GTEx:  ENSG00000138002 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ9UG01
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.10 Å
  • R-Value Free:  0.238 (Depositor), 0.220 (DCC) 
  • R-Value Work:  0.189 (Depositor) 
  • R-Value Observed: 0.192 (Depositor) 
Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 46.967α = 90
b = 90.507β = 97.42
c = 67.423γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
pointlessdata scaling
XDSdata reduction
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Novo Nordisk FoundationDenmarkNNF23OC0085823

Revision History  (Full details and data files)

  • Version 1.0: 2024-12-04
    Type: Initial release
  • Version 1.1: 2026-06-10
    Changes: Database references
  • Version 1.2: 2026-07-08
    Changes: Database references